Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers

A quantifier-based fuzzy classification system for breast cancer patients

(2013) Daniele Soria et al.   ARTIFICIAL INTELLIGENCE IN MEDICINE

p53 Status Identifies Two Subgroups of Triple-negative Breast Cancers with Distinct Biological Features

(2011) E. Biganzoli et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients

(2010) Daniele Soria et al.   COMPUTERS IN BIOLOGY AND MEDICINE

Determination ofHER2amplification in primary breast cancer using dual-colour chromogenicin situhybridization is comparable to fluorescencein situhybridization: a European multicentre study involving 168 specimens

(2010) Tomás García-Caballero et al.   HISTOPATHOLOGY

Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

(2010) Fiona M. Blows et al.   PLOS MEDICINE

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH